Lexaria Bioscience Corp.
LEXX
$4.52
-$1.35-22.93%
NASDAQ
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.62M | 5.27M | 4.42M | 1.97M | 4.63M |
| Total Receivables | 49.00K | 42.00K | 88.00K | 368.40K | 358.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 398.80K | 458.80K | 850.60K | 1.13M | 823.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.06M | 5.77M | 5.36M | 3.47M | 5.81M |
|
|
|||||
| Total Current Assets | 4.06M | 5.77M | 5.36M | 3.47M | 5.81M |
| Net Property, Plant & Equipment | 313.40K | 334.90K | 315.60K | 334.90K | 354.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 339.00K | 318.10K | 308.10K | 307.80K | 516.40K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 64.00K | 64.00K | 64.00K | 64.00K | 64.00K |
| Total Assets | 4.78M | 6.49M | 6.05M | 4.18M | 6.74M |
|
|
|||||
| Total Accounts Payable | 104.60K | 36.20K | 1.18M | 569.80K | 597.50K |
| Total Accrued Expenses | 245.80K | 146.40K | 249.00K | 893.30K | 860.80K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 33.00K | 32.10K | 31.10K | 30.40K | 29.90K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 383.40K | 214.70K | 1.46M | 1.49M | 1.49M |
|
|
|||||
| Total Current Liabilities | 383.40K | 214.70K | 1.46M | 1.49M | 1.49M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 53.70K | 62.30K | 70.80K | 78.90K | 86.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 437.10K | 277.00K | 1.53M | 1.57M | 1.57M |
|
|
|||||
| Common Stock & APIC | 73.28M | 73.16M | 70.04M | 66.52M | 66.40M |
| Retained Earnings | -68.50M | -66.51M | -65.06M | -63.46M | -60.76M |
| Treasury Stock & Other | -46.50K | -55.40K | -76.10K | -70.30K | -81.10K |
| Total Common Equity | 4.74M | 6.60M | 4.91M | 2.99M | 5.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.74M | 6.60M | 4.91M | 2.99M | 5.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -394.00K | -392.20K | -389.40K | -386.90K | -385.60K |
| Total Equity | 4.34M | 6.21M | 4.52M | 2.60M | 5.17M |
|
|
|||||